Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up Global estimates indicated 2.3 million new cases of breast cancer in 2020, contributing

Recommendations for the use of next-generation sequencing (NGS) Considering the evolving field of drug development and genomic data, the European Society for Medical Oncology (ESMO)

Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline Hereditary breast and ovarian cancer syndrome (HBOC) is clinically defined

ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer Metastatic breast cancer (MBC) is an incurable disease, but